Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Laura Gurskyte"'
Autor:
Efstathios Kastritis, Arpit Misra, Laura Gurskyte, Florint Kroi, Andre Verhoek, Jessica Vermeulen, Eric Ammann, Annette Lam, Sarah Cote, Ashutosh D. Wechalekar
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives: Amyloid light-chain (AL) amyloidosis is a rare disease characterized by amyloid fibril deposits made up of toxic light chains causing progressive organ dysfunction and death. Recent studies suggest that hematologic response may be
Externí odkaz:
https://doaj.org/article/4c7982a23cd841e7bbdd0d78214e0fd9
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 10 (2023)
Failure to adjust for effect modifiers (EMs) in indirect treatment comparisons (ITCs) can produce biased and uncertain effect estimates. This is particularly important for health technology assessments (HTAs), where the availability of new treatmen
Externí odkaz:
https://doaj.org/article/fbfca314c5474476bf897a2f5e2752b7
Autor:
T Alexander Russell-Smith, Laura Gurskyte, Bogdan Muresan, Carla M Mamolo, Ana Gezin, Joseph C Cappelleri, Bart Heeg
Publikováno v:
Future Oncology. 18:2029-2039
Some patients with acute myeloid leukemia (AML) have no response to initial treatment or have a response that is subsequently lost. Follow-on treatment options after that initial stage are limited, especially for patients who are not able to have int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ac099498d9f4a75609c2c6a23a9d841
https://doi.org/10.2217/fon-2021-1355
https://doi.org/10.2217/fon-2021-1355
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S40-S40
IntroductionUnadjusted effect modifiers (EM) in indirect treatment comparisons (ITC) can produce biased and uncertain results in health technology assessments (HTA). Even though research on advanced ITC methods to adjust for EMs has attracted much at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec85953a6a411e552753e584aebdd76d
https://doi.org/10.1017/s0266462322001507
https://doi.org/10.1017/s0266462322001507
Autor:
Ashutosh D. Wechalekar, Efstathios Kastritis, Florint Kroi, Annette Lam, Jessica Vermeulen, Arpit Misra, Eric M. Ammann, Sarah Cote, Laura Gurskyte
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S43-S44
Background Amyloid light-chain (AL) amyloidosis is a rare disease characterized by amyloid fibril deposits made up of toxic light chains causing organ dysfunction and death. Prompt treatment is crucial to achieve deep hematologic responses, reverse o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33c2e9a7a65df7201d6d32594ed29504
https://doi.org/10.1016/s2152-2650(21)02143-1
https://doi.org/10.1016/s2152-2650(21)02143-1
Autor:
Margarita Kulakova, Mark S. Berger, S. Gebregergish, Anil Kapur, Jugna Shah, Rajneesh Nath, Vijay Reddy, Laura Gurskyte, Bart Heeg
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S104-S105
Background Allogeneic stem cell transplantation (allo-SCT) is an effective, potentially curative treatment for acute myeloid leukemia (AML) patients. Inpatient stay accounts for the majority of healthcare resource use (HCRU) associated with the proce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cba078f2733f895631bebb7041603f28
https://doi.org/10.1016/j.bbmt.2018.12.376
https://doi.org/10.1016/j.bbmt.2018.12.376
Autor:
S. Gebregergish, Mark S. Berger, Vijay Reddy, Bart Heeg, Rajneesh Nath, Anil Kapur, Margarita Kulakova, Laura Gurskyte
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S125
Background The prognosis of patients with R/R AML is poor. The aim of salvage therapy in R/R AML patients is to bring patients to complete response (CR) and subsequently proceed to SCT. CR rate is generally low among R/R AML patients, particularly af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d91e5016aec77142c68e7d93bfe8389a
https://doi.org/10.1016/j.bbmt.2018.12.407
https://doi.org/10.1016/j.bbmt.2018.12.407